Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ReShape Medical
MedTech
Nerve stimulation device maker electroCore lists $78M IPO
Bioelectronic medicine developer electroCore is going public with a $78 million IPO, listing 5.2 million shares of common stock at $15.00 per share.
Conor Hale
Jun 22, 2018 9:49am
ReShape unveils $6M offering, stock falls 50%
Apr 2, 2018 10:50am
Enteromedics rebrands as ReShape LifeSciences—News of Note
Oct 25, 2017 11:42am
FDA updates gastric balloon warning after 5 deaths
Aug 11, 2017 11:42am
Allurion bumps up series C to $27M as it revs up for U.S. trial
Jul 11, 2017 9:30am
Adverse events prompt FDA warning about obesity devices
Feb 10, 2017 4:48am
